We found that 34.49% (318/ 922) of BC samples harbored PIK3CA mutations (28.30% were exon 9 mutations, 33.65% were exon 20 mutations, and 38.05% were other types of mutations) (Fig. 1C). This evidence concerns the gene PIK3CA and breast cancer.